DE2518270A1 - Verfahren zur herstellung von leicht zerfallenden tabletten - Google Patents
Verfahren zur herstellung von leicht zerfallenden tablettenInfo
- Publication number
- DE2518270A1 DE2518270A1 DE19752518270 DE2518270A DE2518270A1 DE 2518270 A1 DE2518270 A1 DE 2518270A1 DE 19752518270 DE19752518270 DE 19752518270 DE 2518270 A DE2518270 A DE 2518270A DE 2518270 A1 DE2518270 A1 DE 2518270A1
- Authority
- DE
- Germany
- Prior art keywords
- methyl cellulose
- weight
- tablets
- mixture
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 35
- 238000004519 manufacturing process Methods 0.000 title description 8
- 229920000609 methyl cellulose Polymers 0.000 claims description 63
- 239000001923 methylcellulose Substances 0.000 claims description 63
- 235000010981 methylcellulose Nutrition 0.000 claims description 63
- 239000008187 granular material Substances 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000007884 disintegrant Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 238000006467 substitution reaction Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 239000011877 solvent mixture Substances 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 159000000007 calcium salts Chemical class 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- -1 hydroxypropoxy groups Chemical group 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 238000005469 granulation Methods 0.000 description 11
- 230000003179 granulation Effects 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 7
- 108010019160 Pancreatin Proteins 0.000 description 6
- 229940055695 pancreatin Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 4
- 239000008116 calcium stearate Substances 0.000 description 4
- 235000013539 calcium stearate Nutrition 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000012907 medicinal substance Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4787574A JPS5438167B2 (https=) | 1974-04-27 | 1974-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2518270A1 true DE2518270A1 (de) | 1976-03-18 |
Family
ID=12787543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752518270 Pending DE2518270A1 (de) | 1974-04-27 | 1975-04-24 | Verfahren zur herstellung von leicht zerfallenden tabletten |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US4017598A (https=) |
| JP (1) | JPS5438167B2 (https=) |
| DE (1) | DE2518270A1 (https=) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009858A1 (en) * | 1978-10-02 | 1980-04-16 | The Speywood Laboratory Ltd. | Gum granulates, and their preparation and use |
| WO1984000760A1 (en) * | 1982-08-06 | 1984-03-01 | James River Corp | Cellulose granules and process for producing the same |
| EP0205282A3 (en) * | 1985-06-11 | 1987-08-26 | Euroceltique Sa | Oral pharmaceutical composition |
| US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
| US4734285A (en) * | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
| EP0281200A1 (en) * | 1987-03-02 | 1988-09-07 | Yamanouchi Europe B.V. | Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
| EP0330284A3 (en) * | 1988-02-25 | 1990-11-07 | Gist-Brocades N.V. | Pharmaceutical granulate |
| US5211958A (en) * | 1987-11-30 | 1993-05-18 | Gist-Brocades, N.V. | Pharmaceutical composition and process for its preparation |
| US6372253B1 (en) * | 1997-08-22 | 2002-04-16 | Smithkline Beecham Corporation | Rapidly disintegrating methylcellulose tablets |
| US7125562B2 (en) | 1997-08-22 | 2006-10-24 | Smithkline Beecham Corporation | Rapidly disintegrating methylcellulose tablets |
| US9919007B2 (en) | 2013-03-15 | 2018-03-20 | Braintree Laboratories, Inc. | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5332111A (en) * | 1976-09-07 | 1978-03-27 | Asahi Chem Ind Co Ltd | Composition for tablet |
| US4115292A (en) * | 1977-04-20 | 1978-09-19 | The Procter & Gamble Company | Enzyme-containing detergent articles |
| US4176079A (en) * | 1977-04-20 | 1979-11-27 | The Procter & Gamble Company | Water-soluble enzyme-containing article |
| CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
| US4547358A (en) * | 1980-05-06 | 1985-10-15 | Mead Johnson & Company | Sustained release tablet containing at least 95 percent theophylline |
| US4465660A (en) * | 1981-04-01 | 1984-08-14 | Mead Johnson & Company | Sustained release tablet containing at least 95 percent theophylline |
| US4738851A (en) * | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| JPS62110739A (ja) * | 1985-11-06 | 1987-05-21 | Dai Ichi Kogyo Seiyaku Co Ltd | 水溶性セルロ−ス誘導体の顆粒化法 |
| US5624683A (en) * | 1986-08-06 | 1997-04-29 | Eisai Co., Ltd. | Sustained-release multi-granule tablet |
| GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| FR2707878A1 (fr) * | 1993-07-21 | 1995-01-27 | Imedex | Nouvelles compositions adhésives à usage chirurgical. |
| US5807578A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| PT1166651E (pt) * | 1996-02-29 | 2005-04-29 | Fujisawa Pharmaceutical Co | Granulos de desintegracao rapida de um edulcorante sintetico contendo acido silicico e/ou dioxido de silicio |
| CN1157453C (zh) * | 1997-07-17 | 2004-07-14 | 亨克尔两合股份公司 | 制造水性粘合剂体系的凝聚体 |
| FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| AU2004237813B2 (en) * | 1997-08-22 | 2007-06-28 | Smithkline Beecham Corporation | Rapidly disintegrating methylcellulose tablets |
| CA2342625A1 (en) * | 1998-09-08 | 2000-03-16 | Smithkline Beecham Corporation | Lipstatin derivative-soluble fiber tablets |
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| CA2348452A1 (en) * | 1998-10-27 | 2000-05-04 | Biovail Technologies Ltd. | Microparticles containing peg and/or peg glyceryl esters |
| JP4808960B2 (ja) | 2002-05-14 | 2011-11-02 | エフ エム シー コーポレーション | 微結晶質セルロース組成物 |
| RU2225724C1 (ru) * | 2002-08-01 | 2004-03-20 | Закрытое акционерное общество "Брынцалов-А" | Ферментный препарат "панзим форте" |
| WO2005009395A2 (en) * | 2003-07-23 | 2005-02-03 | L. Perrigo Company | Cellulosic fiber containing composition |
| FR2858556B1 (fr) * | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
| KR100882156B1 (ko) * | 2003-08-08 | 2009-02-06 | 아지노모토 가부시키가이샤 | 나테글리니드 함유 제제 |
| US7956222B2 (en) * | 2004-08-17 | 2011-06-07 | Eisai R&D Management Co., Ltd | Methods for producing dibromofluorobenzene derivatives |
| US7344907B2 (en) * | 2004-11-19 | 2008-03-18 | International Business Machines Corporation | Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale |
| US7879382B2 (en) * | 2005-09-30 | 2011-02-01 | Fmc Corporation | Stabilizers and compositions and products comprising same |
| US20070243248A1 (en) * | 2006-04-14 | 2007-10-18 | Cherukuri S Rao | Rapidly disintegrating solid oral dosage form of liquid dispersions |
| BR112014007366B1 (pt) | 2011-10-05 | 2020-09-15 | Dupont Nutrition Usa, Inc | Processo para fabricar uma composição estabilizadora compreendendo extrusão em duas etapas, composição estabilizadora de celulose microcristalina e produto alimentício comestível e suspensão industrial compreendendo a mesma |
| ES2657648T3 (es) | 2011-10-05 | 2018-03-06 | Fmc Corporation | Composición estabilizadora de celulosa microcristalina y carboximetilcelulosa co-reducida, método para elaborarla y usos |
| EP2787837B1 (en) | 2011-12-09 | 2017-03-15 | FMC Corporation | Co-attrited stabilizer composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2883327A (en) * | 1954-05-03 | 1959-04-21 | Upjohn Co | Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof |
| US3079303A (en) * | 1958-12-11 | 1963-02-26 | Smith Kline French Lab | Basic tablet granulation and process of using same |
| US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
| US3133863A (en) * | 1961-03-10 | 1964-05-19 | Strong Cobb Arner Inc | Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums |
| BE627516A (https=) * | 1962-01-25 | |||
| US3852421A (en) * | 1970-03-23 | 1974-12-03 | Shinetsu Chemical Co | Excipient and shaped medicaments prepared therewith |
| US3725556A (en) * | 1970-11-12 | 1973-04-03 | D Hanssen | Method of manufacturing rapidly disintegrating pharmaceutical tablets |
| IL43853A0 (en) * | 1973-02-16 | 1974-03-14 | Sparamedica Ag | Pharmaceutical compositions and their manufacture |
-
1974
- 1974-04-27 JP JP4787574A patent/JPS5438167B2/ja not_active Expired
-
1975
- 1975-04-22 US US05/570,959 patent/US4017598A/en not_active Expired - Lifetime
- 1975-04-24 DE DE19752518270 patent/DE2518270A1/de active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009858A1 (en) * | 1978-10-02 | 1980-04-16 | The Speywood Laboratory Ltd. | Gum granulates, and their preparation and use |
| WO1984000760A1 (en) * | 1982-08-06 | 1984-03-01 | James River Corp | Cellulose granules and process for producing the same |
| US4438263A (en) | 1982-08-06 | 1984-03-20 | James River Corporation Of Virginia | Cellulose granules and process for producing the same |
| EP0205282A3 (en) * | 1985-06-11 | 1987-08-26 | Euroceltique Sa | Oral pharmaceutical composition |
| US4734285A (en) * | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
| US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
| EP0281200A1 (en) * | 1987-03-02 | 1988-09-07 | Yamanouchi Europe B.V. | Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
| US4950484A (en) * | 1987-03-02 | 1990-08-21 | Gist-Brocades N.V. | Pharmaceutical tablet, pharmaceutical granulate and process for their preparation |
| US5211958A (en) * | 1987-11-30 | 1993-05-18 | Gist-Brocades, N.V. | Pharmaceutical composition and process for its preparation |
| EP0330284A3 (en) * | 1988-02-25 | 1990-11-07 | Gist-Brocades N.V. | Pharmaceutical granulate |
| US6372253B1 (en) * | 1997-08-22 | 2002-04-16 | Smithkline Beecham Corporation | Rapidly disintegrating methylcellulose tablets |
| US7125562B2 (en) | 1997-08-22 | 2006-10-24 | Smithkline Beecham Corporation | Rapidly disintegrating methylcellulose tablets |
| US7132114B2 (en) | 1997-08-22 | 2006-11-07 | Smithkline Beecham Corporation | Rapidly disintegrating methylcellulose tablets |
| US9919007B2 (en) | 2013-03-15 | 2018-03-20 | Braintree Laboratories, Inc. | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| US4017598A (en) | 1977-04-12 |
| JPS50140623A (https=) | 1975-11-11 |
| JPS5438167B2 (https=) | 1979-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2518270A1 (de) | Verfahren zur herstellung von leicht zerfallenden tabletten | |
| DE3685927T2 (de) | Vitamine enthaltende granule. | |
| DE69835162T2 (de) | Geschmacksmaskierte pharmazeutische zusammensetzungen | |
| DE68916983T2 (de) | Verfahren zur Herstellung eines pharmazeutischen Granulats. | |
| DE69518820T2 (de) | Rotogranulat und Beschichtung von Acetaminophen, Pseudoephedrin, Chlorpheniramin und, gegebenenfalls, Dextromethorphan | |
| DE69712332T2 (de) | Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung | |
| DE69434479T2 (de) | Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe | |
| DE69915478T2 (de) | Geschmacksmaskierung mittels croscarmellose | |
| DE3877764T2 (de) | Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren. | |
| DE68916731T2 (de) | Morphin enthaltende Zusammensetzung. | |
| DE69023183T2 (de) | Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten. | |
| AT394310B (de) | Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge | |
| DE69110592T2 (de) | Pharmazeutische Zubereitung mit verbessertem Geschmack, poröse Partikel enthaltend, und deren Herstellungsmethode. | |
| DE69400356T2 (de) | Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten | |
| DE1279896B (de) | Die Verwendung eines sauren Copolymerisates zur Herstellung von Tabletten mit verlaengerter Wirkstoffabgabe | |
| DE2808514A1 (de) | Nitrofurantoin enthaltende tablette | |
| CH644759A5 (de) | Pharmazeutisches praeparat mit langsamer wirkstofffreisetzung und verfahren zu dessen herstellung. | |
| EP0582186A1 (de) | Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung | |
| CH647949A5 (de) | Cholestyramin-enthaltende pharmazeutische komposition. | |
| DE2224534A1 (de) | Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe | |
| EP0009688B1 (de) | Medikiertes Tierfutter auf Basis Lebermehl und Verfahren zu seiner Herstellung | |
| DD284600A5 (de) | Zusammensetzung, die auf der oberflaeche von pharmazeutischen granulaten verwendet werden kann | |
| DE10003757A1 (de) | Ibuprofen-Wirkstoffzubereitung | |
| DE69624364T2 (de) | Abführmittel enthaltend lactitol und psyllium | |
| DE69111574T2 (de) | Polycarbophil-Kalzium enthaltendes Arzneimittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |